EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Tissue Expression of NLRP3, IL‐1β, and IL‐18 in Glomerular and Interstitial Inflammation Associated With Diabetic Nephropathy

Bruna de Freitas Oliveira, Liliane Silvano Araújo, Crislaine Aparecida da Silva, Laura Penna Rocha, Raíssa Bernardes da Silva, Marlene Antônia dos Reis, Rafael Obata Trevisan, Bruna Cunha Zaidan, Juliana Reis Machado

Mediators of Inflammation · 2026-01 · 2026 (1)

DOI: 10.1155/mi/9937801 ↗
AbstractBibliografische Angaben

Abstract

Activation of the NLRP3 inflammasome and its downstream cytokines IL‐1β and IL‐18 has been increasingly associated with the inflammatory mechanisms underlying diabetic nephropathy (DN), the leading cause of chronic kidney disease and end‐stage renal disease worldwide. This study investigated the expression of these inflammatory mediators in renal tissue from patients with DN. Eighty renal biopsies from adult patients (≥18 years) with a histopathological diagnosis of DN and 22 control samples obtained from autopsies were analyzed. NLRP3, IL‐1β, and IL‐18 expression was assessed by immunohistochemistry, and semi‐quantitative analysis was performed to determine the proportion of immunostained cells in the glomerular and interstitial compartments. A significant increase in immunostaining for all three mediators was observed in mesangial cells, podocytes, endothelial cells, and the interstitium of DN samples compared with controls ( p < 0.05). Positive and significant correlations were found between NLRP3 and IL‐1β in endothelial cells ( p < 0.0001; rS = 0.4720) and in the interstitium ( p = 0.0230; rS = 0.2540), as well as between NLRP3 and IL‐18 in podocytes ( p = 0.0055; rS = 0.3074). Moreover, interstitial expression of NLRP3 and IL‐1β correlated positively with serum creatinine levels ( p = 0.0015; rS = 0.3708; and p = 0.0029; rS = 0.3480, respectively), suggesting an association between inflammasome‐mediated inflammation and renal dysfunction. Collectively, these findings indicate that the NLRP3/IL‐1β/IL‐18 axis plays a central role in glomerular and interstitial injury in DN, supporting its potential as a prognostic biomarker and a promising therapeutic target for disease modulation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →